Business Today
Subscribe
PMS TodayUS NewsIndiaUPSTARTWeatherBT ShortsNRIEducationElection
BT GolfBT MindrushBT Best Banks
Search

COMPANIES

No Data Found

NEWS

No Data Found
Advertisement
News
markets
stocks
Ajanta Pharma Ltd
Ajanta Pharma Ltd

Ajanta Pharma Ltd (AJANTPHARM) Share Price

  • Sector: Pharmaceuticals (Mid Cap)
  • Volume: 68,055
Apr 25, 2025
  • NSE
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹2,676.00
₹-114.40 (-4.10%)
2,664.50Low
Today’s Performance
2,829.40High
2,111.05Low
52 Week’s Performance
3,485.00High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day-4.10%
  • 1 Week-0.12%
  • 1 Month-3.54%
  • 3 Months0.38%
  • 6 Months-9.88%
  • 1 Year25.05%
  • 3 Years32.31%
  • 5 Years21.66%

bt_logoPeer Comparison

Price

bt_logoStock Summary

  • Face Value (₹)2.00
  • Beta0.57
  • 52-Week Low (₹)2,111.05
  • 52-Week High (₹)3,485.00
  • Price-to-Book (X)*9.10
  • Dividend Yield (%)1.93
  • Price-to-Earnings (P/E) (X)*37.25
  • Earnings Per Share (₹)71.88
  • Market Cap (₹ Cr.)*33,426.48
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Trump Tariff| Kenneth Andrade on India’s Resilience Amid Trade Uncertaint1:33Trump Tariff | Kenneth Andrade on India’s Resilience Amid Trade Uncertainty
Being Polite To ChatGPT Could Be Costing Millions: The Shocking Reality Behind AI's Hidden Energy4:38Being Polite To ChatGPT Could Be Costing Millions: The Shocking Reality Behind AI's Hidden Energy
Understanding The Impact Of India’s Suspension Of The Indus Water Treaty On Pakistan5:16Understanding The Impact Of India’s Suspension Of The Indus Water Treaty On Pakistan
Jim Rogers: India’s Shift Toward Prosperity Makes Its Market a Global Investor’s Dream0:54Jim Rogers: India’s Shift Toward Prosperity Makes Its Market a Global Investor’s Dream
From Cement To Coal: Best Domestic Plays Amid Global Trade Uncertainty1:43From Cement To Coal: Best Domestic Plays Amid Global Trade Uncertainty
Pahalgam Attack: Emotional Burst Of Victims, Survivors & Kashmiri Locals2:58Pahalgam Attack: Emotional Burst Of Victims, Survivors & Kashmiri Locals
Domestic Focus, Global Reach: Jindal Stainless8:54Domestic Focus, Global Reach: Jindal Stainless
Piyush Goyal Urges Industry To Back 'Make In India', Warns Against Irregular Trade Practices3:40Piyush Goyal Urges Industry To Back 'Make In India', Warns Against Irregular Trade Practices
Nine Indian Banks Among Forty Global Digital Champions: Deloitte Report19:05Nine Indian Banks Among Forty Global Digital Champions: Deloitte Report
India-Pak Tensions Rattle Markets | Sensex Tanks 400 Pts, Nifty Sees Sharp Drop8:47India-Pak Tensions Rattle Markets | Sensex Tanks 400 Pts, Nifty Sees Sharp Drop
View more

bt_logoFinancial Analysis

Income Statement (₹ Cr.)

No data for consolidated quarterly .

Balance Sheet (₹ Cr.)

No data for consolidated quarterly .

Cash Flow (₹ Cr.)

No data for consolidated quarterly .

bt_logoRatio Analysis

Return on Equity (%)
No Data For consolidated ROE.
Return on Assets (%)
No Data For consolidated ROE.
Price-to-Earnings (P/E) (X)
No Data For consolidated ROE.
Price to Book (x)
No Data For consolidated ROE.
Return on Capital Employed (%)
No Data For consolidated ROE.
Enterprise Value to EBITDA (X)
No Data For consolidated ROE.
Net Profit Margin (%)
No Data For consolidated ROE.
Gross Profit Margin (%)
No Data For consolidated ROE.
EBITDA Margin (%)
No Data For consolidated ROE.

bt_logoShare Holding Pattern

Summary (As on 31 Mar 2025)

bt_logoDeals

25 Jan, 2024BUY
SOCIETE GENERALE
Qty125617
Average Price₹2195.5
25 Jan, 2024BUY
MARSHALLWACEINVESTMENTSTRATEGIESMARKETNEUTRALTOPSFUND
Qty47901
Average Price₹2195.5
25 Jan, 2024SELL
BNP PARIBAS ARBITRAGE
Qty50586
Average Price₹2195.5
25 Jan, 2024BUY
MARSHALL WACE INVESTMENT STRATEGIESGTOPS FUND
Qty2685
Average Price₹2195.5
25 Jan, 2024SELL
BNP PARIBAS ARBITRAGE
Qty125617
Average Price₹2195.5
22 Dec, 2022BUY
ABS DIRECT EQUITY FUND LLC - INDIA SERIES 1
Qty21356
Average Price₹1160.1
*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.

bt_logoFAQ's

What was Ajanta Pharma Ltd share price previously?
Ajanta Pharma Ltd share price was down by -4.10% from the previous closing price of ₹2,790.40.
Who are peers of Ajanta Pharma Ltd?
The peers of Ajanta Pharma Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd.
Who is/are the promoter/promoters of Ajanta Pharma Ltd?
The promotor/promotors of Ajanta Pharma Ltd are Mannalal B Agrawal, Madhusudan B Agrawal, Yogesh Agrawal, Chandrakanth M Khetan, Gaurang Shah, Rajesh M Agrawal, K H Viswanathan, Prabhakar Dalal, Anjana Grewal, David Rasquinha, Medha Joshi, Simi Thapar, Rajesh Shashikant Dalal.
What has been 52-week high of Ajanta Pharma Ltd stocks?
The highest price of Ajanta Pharma Ltd stock is ₹3,485.00 in the last 52-week.
What is the share price of Ajanta Pharma Ltd (AJANTPHARM) today on NSE?
As on Apr 25, 2025 Ajanta Pharma Ltd (AJANTPHARM)’s share price on NSE is Rs 2676
What is the market cap of Ajanta Pharma Ltd (AJANTPHARM)?
The current market capitalisation of Ajanta Pharma Ltd (AJANTPHARM) is 33,426.48 crores
What is Ajanta Pharma Ltd Share symbol?
The symbol of Ajanta Pharma Ltd is AJANTPHARM.
What is the PE ratio of Ajanta Pharma Ltd (AJANTPHARM)?
The current PE ratio of Ajanta Pharma Ltd (AJANTPHARM) is 37.25.
What is the PB ratio of Ajanta Pharma Ltd (AJANTPHARM)?
The current PB ratio of Ajanta Pharma Ltd (AJANTPHARM) is 9.10.
Today’s High & Low share prices of Ajanta Pharma Ltd (AJANTPHARM) on NSE?
Today, the share price of Ajanta Pharma Ltd (AJANTPHARM) on NSE touched a high of Rs 2829.4 and a low of Rs 2664.5
What price did Ajanta Pharma Ltd (AJANTPHARM) shares open on the NSE today?
On NSE, the share price of Ajanta Pharma Ltd (AJANTPHARM) opened at Rs 2800.4
What is the 52-week high of Ajanta Pharma Ltd (AJANTPHARM)?
The 52-week high price of Ajanta Pharma Ltd (AJANTPHARM) is Rs 3,485.00
What is the 52-week low of Ajanta Pharma Ltd (AJANTPHARM)?
The 52-week low price of Ajanta Pharma Ltd (AJANTPHARM) is Rs 2,111.05

bt_logoAbout Ajanta Pharma

Ajanta Pharma Ltd, incorporated in the year 1979, has its registered office in Ajanta House, Charkop Kandivli (W), Mumbai, Maharashtra, 400067, 91-22-66061000/1204/1203, 91-22-66061200/1300. The main industry in which Ajanta Pharma Ltd operates is Pharmaceuticals - Indian - Formulations.

Auditor/Auditors for Ajanta Pharma Ltd is/are B S R & Co LLP. In the main management, Mannalal B Agrawal is chairman and Gaurang Shah is the company secretary for Ajanta Pharma Ltd.

  • MBA
    Mannalal B AgrawalChairman (Non-Executive)
  • MBA
    Madhusudan B AgrawalVice Chairman
  • YA
    Yogesh AgrawalManaging Director
  • CMK
    Chandrakanth M KhetanIndependent Director
  • GS
    Gaurang ShahVice President & CS
  • RMA
    Rajesh M AgrawalJoint Managing Director
  • KHV
    K H ViswanathanIndependent Director
  • PD
    Prabhakar DalalIndependent Director
  • AG
    Anjana GrewalIndependent Director
  • DR
    David RasquinhaIndependent Director
  • MJ
    Medha JoshiIndependent Director
  • ST
    Simi ThaparIndependent Director
  • RSD
    Rajesh Shashikant DalalIndependent Director

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.